M
Maroun M. Sfeir
Researcher at University of Connecticut Health Center
Publications - 51
Citations - 1067
Maroun M. Sfeir is an academic researcher from University of Connecticut Health Center. The author has contributed to research in topics: Medicine & Loop-mediated isothermal amplification. The author has an hindex of 11, co-authored 47 publications receiving 471 citations. Previous affiliations of Maroun M. Sfeir include Cornell University & Lebanese University.
Papers
More filters
Journal ArticleDOI
Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay.
Xiong Ding,Kun Yin,Ziyue Li,Rajesh V. Lalla,Enrique Ballesteros,Maroun M. Sfeir,Changchun Liu +6 more
TL;DR: The AIOD-CRISPR method has the significant potential to provide a rapid, sensitive, one-pot point-of-care assay for SARS-CoV-2.
Journal ArticleDOI
EDTA-Modified Carbapenem Inactivation Method: a Phenotypic Method for Detecting Metallo-β-Lactamase-Producing Enterobacteriaceae.
Maroun M. Sfeir,Joshua A Hayden,Kathy A. Fauntleroy,Chase A. Mazur,Jennifer K. Johnson,Patricia J. Simner,Sanchita Das,Michael J. Satlin,Stephen G. Jenkins,Lars F. Westblade +9 more
TL;DR: The eCIM had an overall sensitivity and specificity of 100% and was adopted by the Clinical and Laboratory Standards Institute as a method to use in combination with the mCIM to identify MBL-producing Enterobacteriaceae.
Journal ArticleDOI
Sensitive quantitative detection of SARS-CoV-2 in clinical samples using digital warm-start CRISPR assay.
TL;DR: In this article, a digital warm-start CRISPR (dWS-CRISPR) was proposed for sensitive quantitative detection of SARS-CoV-2 in clinical samples.
Journal ArticleDOI
Burkholderia cepacia complex infections: More complex than the bacterium name suggest.
TL;DR: This narrative review aims to highlight an update on the epidemiology, the microbiological diagnostic methods, the antimicrobial resistance mechanisms, and the most current as well the promising therapeutic options for Burkholderia cepacia complex.
Posted ContentDOI
All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus at the Point of Care
Xiong Ding,Kun Yin,Ziyue Li,Rajesh V. Lalla,Enrique Ballesteros,Maroun M. Sfeir,Changchun Liu +6 more
TL;DR: An All-In-One Dual CRISPR-Cas12a assay method for simple, rapid, ultrasensitive, specific, one-pot, and visual detection of coronavirus SARS-CoV- 2 and HIV-1 virus and has significant potential for developing next-generation point-of-care molecular diagnostics.